Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$42K Sell
1,600
-6,200
-79% -$764K 0.01% 749
2023
Q4
$42K Sell
7,800
-20,600
-73% -$2.14M ﹤0.01% 1544
2023
Q3
$11K Buy
28,400
+22,500
+381% +$2.43M ﹤0.01% 2425
2023
Q2
$30K Sell
5,900
-5,400
-48% -$613K ﹤0.01% 1605
2023
Q1
$31K Sell
11,300
-329,600
-97% -$35.6M ﹤0.01% 1656
2022
Q4
$702K Buy
340,900
+55,500
+19% +$5.67M 0.06% 345
2022
Q3
$1.4M Sell
285,400
-109,300
-28% -$9.76M 0.1% 215
2022
Q2
$2.87M Sell
394,700
-51,400
-12% -$4.56M 0.2% 101
2022
Q1
$1.54M Sell
446,100
-289,900
-39% -$22.9M 0.08% 261
2021
Q4
$2.84M Buy
736,000
+486,300
+195% +$38.7M 0.12% 184
2021
Q3
$1.01M Buy
249,700
+36,200
+17% +$2.75M 0.05% 466
2021
Q2
$414K Buy
213,500
+208,679
+4,329% +$15.5M 0.02% 858
2021
Q1
$17K Hold
4,821
﹤0.01% 3343
2020
Q4
$41K Sell
4,821
-3,458
-42% -$264K ﹤0.01% 2139
2020
Q3
$52K Buy
+8,279
New +$648K ﹤0.01% 1772
2019
Q4
Sell
-3,668
Closed -$1K 4362
2019
Q3
$1K Sell
3,668
-19,388
-84% -$1.55M ﹤0.01% 3768
2019
Q2
$40K Buy
23,056
+21,589
+1,472% +$1.65M ﹤0.01% 1710
2019
Q1
$1K Sell
1,467
-8,070
-85% -$604K ﹤0.01% 3732
2018
Q4
$8K Sell
9,537
-116,642
-92% -$8.23M ﹤0.01% 2662
2018
Q3
$386K Buy
+126,179
New +$8.04M 0.03% 573
2018
Q2
Sell
-20,646
Closed -$5K 4614
2018
Q1
$5K Buy
+20,646
New +$1.12M ﹤0.01% 3292
2017
Q4
Sell
-23,580
Closed -$19K 5526
2017
Q3
$19K Buy
23,580
+7,965
+51% +$483K ﹤0.01% 3185
2017
Q2
$25K Sell
15,615
-212,011
-93% -$12.9M ﹤0.01% 3191
2017
Q1
$106K Buy
227,626
+190,736
+517% +$11.6M ﹤0.01% 1678
2016
Q4
$54K Buy
36,890
+12,367
+50% +$724K ﹤0.01% 2462
2016
Q3
$74K Sell
24,523
-734
-3% -$42.9K ﹤0.01% 2078
2016
Q2
$35K Sell
25,257
-65,814
-72% -$3.5M ﹤0.01% 2734
2016
Q1
$84K Sell
91,071
-234,019
-72% -$11.5M 0.01% 1787
2015
Q4
$462K Buy
+325,090
New +$16.4M 0.03% 661

Other funds holding MRK

Cutler Group's MRK Position: Q4 2023 in Review

Cutler Group sold out of Merck (MRK) in Q4 2023, closing a stake of 4,817 shares — an estimated $500K sold.

Cutler Group first reported a position in MRK in Q4 2015 and held it in 27 quarters. The position peaked at $6.25M in Q2 2016. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Cutler Group reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 4,817 Merck shares in Q4 2023, an estimated $500K.
  • Cutler Group first reported a position in Merck in Q4 2015 and held it in 27 quarters.
  • Cutler Group's Merck position peaked at $6.25M in Q2 2016.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.